American Oncology Network and MiBA Launch Real-Time Data Partnership for Clinical Research

Reuters
Jan 15
<a href="https://laohu8.com/S/AONC">American Oncology Network</a> and MiBA Launch Real-Time Data Partnership for Clinical Research

American Oncology Network Inc. $(AON)$, through its research arm American Oncology Research, has announced a strategic partnership with Meaningful Insights Biotech Analytics, LLC (MiBA). This collaboration aims to modernize community-based clinical research by integrating real-time, AI-enhanced data intelligence into AON’s operational infrastructure. By embedding MiBA’s advanced data workflows directly into AON’s clinical environment, the partnership seeks to streamline site selection, patient matching, and trial enrollment. The initiative is designed to close gaps between study design and patient access, enabling research teams to identify eligible patients more quickly and open trials more efficiently. The alliance also enhances provider engagement by integrating clinical trial opportunities into the Electronic Medical Record $(EMR)$ system, ensuring trials are presented as immediate care options for oncology patients.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9625939-en) on January 15, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10